Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Enright Patrick G
Relationship:   10% Owner
City:   Burlingame
State:   CA
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   3,308,185    

Indirect Shares

   27,432,603      
Direct Value   $8,963,626    

Indirect Value

   $114,702,131      
Total Shares   30,740,788      
Total Value   $123,665,757      


Molecular Templates, Inc. $298 Sequenom Inc $0 Corcept Therapeutics Inc $6,665,439 Jazz Pharmaceuticals Inc $2,288,769 Aptinyx Inc. $9,120 Eargo, Inc. $0 Molecular Templates, Inc. $298 Sequenom Inc $0 Corcept Therapeutics Inc $6,665,439 Jazz Pharmaceuticals Inc $2,288,769 Aptinyx Inc. $9,120 Eargo, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    6   
    1    

     Stock price went up :
    5   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   5.0   
   1.0   
     Percentage Gain/Loss :
   95.0%
 101.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM Director 2006-04-20 496 2007-03-01 0    Premium*  
            Sequenom Inc SQNM Director 2006-12-07 771 2006-12-07 3,333,333    Premium*  
            Corcept Therapeutics Inc CORT Director 2017-03-16 272,281 2017-03-16 114,675    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 20,946 2022-08-08 2,000    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2013-07-01 0 2015-03-19 18,361    Premium*  
            Collegium Pharmaceutical, Inc COLL 10% Owner 2015-05-12 0 2015-05-12 65,270    Premium*  
            Aimmune Therapeutics, Inc. AIMT Director 2020-10-13 0 2020-10-10 0    Premium*  
            Aptinyx Inc. APTX Director 2020-01-10 95,000 2020-01-10 3,356,746    Premium*  
            Tricida, Inc. TCDA 2018-07-02 0 2018-07-02 3,019,734    Premium*  
            Venus Concept Inc VERO 10% Owner 0 2019-11-07 3,666,119    Premium*  
            89bio, Inc. ETNB 10% Owner 2019-11-11 0 2020-11-16 891    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2020-01-29 0 2022-01-25 1,964,771    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2022-04-19 4,174,379    Premium*  
            Eargo, Inc. EAR 10% Owner 2021-04-14 2,918,691 2021-04-14 5,012    Premium*  
            Vera Therapeutics, Inc. VERA Director, 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Lexeo Therapeutics, Inc. LXEO 10% Owner 2023-11-07 0 2023-11-07 2,567,100    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CORT Corcept Therapeutics Inc Director   –       •       •   2008-03-25 3 IO $0.00 $0 I/I 0 3,530,450 -
VERO Venus Concept Inc 10% Owner   –       –       •   2019-11-07 3 IO $0.00 $0 I/I 0 3,666,119 -
MTEM Molecular Templates, Inc. Director   –       •      –    2006-03-03 4 A $0.00 $0 D/D 248 248 -
MTEM Molecular Templates, Inc. Director   –       •      –    2006-04-20 4 A $0.00 $0 D/D 248 496 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-08-25 4 AS $148.40 $52,088 D/D (351) 1,717 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-11-17 4 AS $133.19 $46,883 D/D (352) 1,365 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-12-02 4 S $148.49 $62,960 D/D (424) 1,310 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-27 4 S $167.87 $71,345 D/D (425) 1,734 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-08-15 4 S $136.45 $86,373 D/D (633) 2,042 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-08-11 4 S $142.36 $94,248 D/D (662) 2,068 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-12-02 4 AS $101.80 $68,919 D/D (677) 1,365 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2019-08-09 4 S $135.65 $98,481 D/D (726) 17,663 0 -
SQNM Sequenom Inc Director   –       •      –    2006-12-07 4 A $0.00 $0 D/D 771 771 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-10 4 AS $179.98 $144,178 D/D (801) 2,159 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-10-09 4 S $30.00 $28,290 I/I (943) 37,757 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2013-08-13 4 S $81.86 $87,590 D/D (1,070) 3,430 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-08-12 4 S $133.15 $144,734 D/D (1,087) 3,993 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2022-08-08 4 S $152.33 $165,883 D/D (1,089) 24,086 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2023-08-14 4 S $138.16 $171,455 D/D (1,241) 20,946 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-07 4 A $0.00 $0 D/D 1,310 2,960 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-08-11 4 A $0.00 $0 D/D 1,365 2,675 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-08-10 4 A $0.00 $0 D/D 1,365 2,730 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2018-08-10 4 S $175.13 $239,057 D/D (1,365) 16,469 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2018-08-09 4 A $0.00 $0 D/D 1,495 17,834 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2013-01-11 4 AS $56.54 $90,463 I/I (1,600) 32,898 0 -
  169  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us